The therapeutic strategy of drug re-positioning to induce autophagic cell death in brain malignancy

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Omoruyi SI, Ekpo OE, Semenya DM, Jardine A, Prince S (2020) Exploitation of a novel phenothiazine derivative for its anti-cancer activities in malignant glioblastoma. Apoptosis 25:261–274

    CAS  Article  Google Scholar 

  2. 2.

    Dolma S, Selvadurai HJ, Lan X et al (2016) Inhibition of dopamine receptor D4 impedes autophagic flux, proliferation, and survival of glioblastoma stem cells. Cancer Cell 29:859–873

    CAS  Article  Google Scholar 

  3. 3.

    Shchors K, Massaras A, Hanahan D (2015) Dual targeting of the autophagic regulatory circuitry in gliomas with repurposed drugs elicits cell-lethal autophagy and therapeutic benefit. Cancer Cell 28:456–471

    CAS  Article  Google Scholar 

  4. 4.

    Yoshida GJ (2017) Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment. J Hematol Oncol 10:67

    Article  Google Scholar 

  5. 5.

    Sehm T, Fan Z, Ghoochani A et al (2016) Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema. Oncotarget 7:36021–36033

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Go J. Yoshida.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yoshida, G.J. The therapeutic strategy of drug re-positioning to induce autophagic cell death in brain malignancy. Apoptosis 25, 457–458 (2020). https://doi.org/10.1007/s10495-020-01617-1

Download citation